Abstract:Glioblastoma (GBM) is the most common and lethal subtype of glioma, characterized by uncontrolled cancer cell proliferation, extensive infiltration, and therapeutic resistance. Ring finger protein 216 (RNF216) is a RING-type E3 ubiquitin ligase aberrantly expressed in multiple human cancers. Tumor protein 53 (p53) is a transcription factor that acts as a tumor suppressor. This study aimed to compare the RNF216 expression in GBM tissues and normal peritumoral tissues and to examine the effects of RNF216 overexpression/knockdown on tumorigenesis, radioresistance, and the p53 pathway in GBM. The results showed that RNF216 was overexpressed in GBM tissues and cell lines, and high RNF216 expression was related to a poor prognosis. RNF216 overexpression promoted GBM cell growth and inhibited apoptosis, while RNF216 knockdown impaired GBM cell growth and enhanced cell death. RNF216 was also highly expressed in recurrent GBM tissues compared with paired primary tumors. The upregulation of RNF216 not only facilitated GBM cell growth but also protected cells against X-ray irradiation-induced apoptosis and DNA damage, while RNF216 knockdown exerted opposite effects. Moreover, the implantation of GBM cells with RNF216 silencing suppressed tumorigenesis and increased radiosensitivity of mice bearing GBM xenografts. Further analysis revealed that RNF216 overexpression reduced the stability of p53 protein via ubiquitination and negatively regulated the p53 pathway, while RNF216 knockdown preserved the p53 protein. In conclusion, RNF216 effectively attenuated radiation-induced apoptosis and DNA damage in GBM via inducing ubiquitination-mediated degradation of p53. These findings suggest the potential therapeutic use of RNF216 inhibition for tumorigenesis and therapeutic resistance in GBM.

Radiation-inducible Protein RbAp48 Contributes to Radiosensitivity of Cervical Cancer Cells

RbAp48, a Novel Inhibitory Factor That Regulates the Transcription of Human Immunodeficiency Virus Type 1.

RbAp48 Is a Critical Mediator Controlling the Transforming Activity of Human Papillomavirus Type 16 in Cervical Cancer

Lin28 Mediates Radiation Resistance Of Breast Cancer Cells Via Regulation Of Caspase, H2a.X And Let-7 Signaling

Data from Genetic Ablation of <i>rbm38</i> Promotes Lymphomagenesis in the Context of Mutant P53 by Downregulating PTEN

Overexpression of RbAp46 facilitates stress-induced apoptosis and suppresses tumorigenicity of neoplastigenic breast epithelial cells.

RBAP96 Mediates Radiosensitivity of Breast Cancer Cells Via Interacting with Retinoblastoma Protein

Radiosensitising Effect of Retinoblastoma Gene (rb94) on Human Lung Adenocarcinoma Cell Line A549

Rb-Associated Protein 46 (rbap46) Suppresses the Tumorigenicity of Adenovirus-Transformed Human Embryonic Kidney 293 Cells

Improvement of Radiation Sensitivity by Inhibiting Expression of the Human LRP16 Gene in Tumor Cells

Effects of the Proapoptotic Regulator Bcl2/Adenovirus Eib 19 Kda-Interacting Protein 3 on Radiosensitivity of Cervical Cancer

Apoptin Sensitizes Radiation-Induced Cell Death in Cervical Carcinoma Hela Cells

GADD45α Sensitizes Cervical Cancer Cells to Radiotherapy Via Increasing Cytoplasmic APE1 Level

Adenovirus-mediated Expression of UHRF1 Reduces the Radiosensitivity of Cervical Cancer HeLa Cells to Γ-Irradiation

MiR-181a Confers Resistance of Cervical Cancer to Radiation Therapy Through Targeting the Pro-Apoptotic PRKCD Gene

RSF-1 Sirna Enhances Tumor Radiosensitivity in Cervical Cancer Via Enhanced DNA Damage, Cell Cycle Redistribution, and Promotion of Apoptosis

RBBP6 Increases Radioresistance and Serves As a Therapeutic Target for Preoperative Radiotherapy in Colorectal Cancer

Inhibiting effects of the combination treatment of retinoblastoma 94 with radiotherapy in a mouse xenograft model

MicroRNA-218 Enhances the Radiosensitivity of Human Cervical Cancer Via Promoting Radiation Induced Apoptosis.

RNF216 Alleviates Radiation-Induced Apoptosis and DNA Damage Through Regulating Ubiquitination-Mediated Degradation of p53 in Glioblastoma